(Q48341443)

10 February 2018

title

Regional heterogeneity of cuprizone-induced demyelination: topographical aspects of the midline of the corpus callosum (English)

1 reference

10 February 2018

1 reference

1 reference

3

A Slowik

1 reference

10 February 2018

T Schmidt

1

1 reference

10 February 2018

H Awad

2

1 reference

10 February 2018

C Beyer

4

1 reference

10 February 2018

M Kipp

5

1 reference

10 February 2018

T Clarner

6

1 reference

10 February 2018

publication date

5 October 2012

1 reference

10 February 2018

Journal of Molecular Neuroscience

published in

1 reference

10 February 2018

volume

49

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

80-88

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s12031-012-9896-0

exact match

0 references

cites work

17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

ADAM12 is expressed by astrocytes during experimental demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Brain-region-specific astroglial responses in vitro after LPS exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

The cuprizone animal model: new insights into an old story

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Pathology of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Late motor decline after accomplished remyelination: impact for progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

The cyclooxygenase-2 pathway via the PGE₂ EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone-induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

In vitro and in vivo models of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9896-0

Lack of cuprizone-induced demyelination in the murine spinal cord despite oligodendroglial alterations substantiates the concept of site-specific susceptibilities of the central nervous system

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23054589

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23054589

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neuronal nitric oxide synthase plays a key role in CNS demyelination

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23054589

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12031-012-9896-0

1 reference

10 February 2018

1 reference

10 February 2018